NPI: 1386291466 · ANAHEIM, CA 92801 · Federally Qualified Health Center (FQHC) · NPI assigned 08/22/2019
Authorized official YOUNG, ROBERT controls 20+ related entities in our dataset. Read more
| Authorized Official | YOUNG, ROBERT (VP, PATIENT FINANCIAL SERVICES) |
| NPI Enumeration Date | 08/22/2019 |
Other providers sharing the same authorized official: YOUNG, ROBERT
| Year | Claims | Total Paid |
|---|---|---|
| 2019 | 112 | $9K |
| 2020 | 15,386 | $1.12M |
| 2021 | 25,703 | $1.50M |
| 2022 | 32,699 | $1.50M |
| 2023 | 37,077 | $1.79M |
| 2024 | 53,292 | $1.84M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| T1015 | Clinic visit/encounter, all-inclusive | 39,796 | 38,550 | $7.56M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 58,447 | 49,969 | $73K |
| 0001A | 718 | 441 | $30K | |
| 0002A | 609 | 375 | $28K | |
| 0071A | 347 | 187 | $18K | |
| 0072A | 220 | 116 | $12K | |
| 0004A | 143 | 86 | $7K | |
| 0012A | 125 | 74 | $6K | |
| 0011A | 197 | 134 | $6K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 5,622 | 4,926 | $4K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2,667 | 2,494 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 5,984 | 5,814 | $1K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 4,491 | 3,369 | $968.24 |
| 0124A | 39 | 39 | $871.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1,143 | 978 | $663.67 |
| 90686 | 214 | 208 | $558.04 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1,073 | 1,066 | $497.01 |
| 90656 | 176 | 135 | $482.77 | |
| 90688 | 94 | 94 | $324.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 9,110 | 8,080 | $304.94 |
| 73630 | 714 | 659 | $262.27 | |
| 71046 | Radiologic examination, chest; 2 views | 515 | 504 | $245.37 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 7,303 | 4,042 | $225.56 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1,270 | 980 | $130.73 |
| 73562 | 240 | 239 | $115.18 | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 64 | 44 | $75.00 |
| G0071 | Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | 102 | 99 | $66.84 |
| 81002 | 4,475 | 3,959 | $46.47 | |
| 85018 | 271 | 221 | $45.99 | |
| 72100 | 70 | 70 | $45.44 | |
| 73030 | 56 | 56 | $38.79 | |
| 3079F | 1,292 | 1,250 | $0.00 | |
| 3074F | 1,221 | 1,182 | $0.00 | |
| 3075F | 379 | 374 | $0.00 | |
| 1126F | 726 | 717 | $0.00 | |
| 3080F | 303 | 289 | $0.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 407 | 378 | $0.00 |
| 3351F | 369 | 345 | $0.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 729 | 606 | $0.00 |
| 1125F | 2,084 | 2,048 | $0.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 19 | 13 | $0.00 |
| 82962 | 203 | 169 | $0.00 | |
| 0134A | 21 | 21 | $0.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 16 | 12 | $0.00 |
| 91301 | 39 | 38 | $0.00 | |
| J3490 | Unclassified drugs | 18 | 15 | $0.00 |
| 0064A | 12 | 12 | $0.00 | |
| 3078F | 1,321 | 1,283 | $0.00 | |
| 1160F | 3,527 | 3,428 | $0.00 | |
| 1159F | 3,622 | 3,517 | $0.00 | |
| 3077F | 1,232 | 1,183 | $0.00 | |
| 81025 | 45 | 36 | $0.00 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 45 | 45 | $0.00 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 72 | 70 | $0.00 |
| 73610 | 82 | 81 | $0.00 | |
| 91300 | 127 | 126 | $0.00 | |
| 99201 | 16 | 16 | $0.00 | |
| 91313 | 21 | 21 | $0.00 | |
| 91312 | 26 | 26 | $0.00 |